The Global DNA Sequencing Market was $5.1 Bn in 2020, and it is expected to reach $17.8 Bn by 2030. It is eventually growing at a commendable high compound annual growth rate CAGR of 13.3% between 2020-2030. The DNA sequencing technique is used to define the order of the nucleotide bases cytosine, thymine, adenine, and guanine in a molecule of DNA. The increasing requirement of breeders for animals and plant production, growing prevalence of cancer, increasing research, development in technology, and development and growth in liquid biopsy applications are the factors that are propelling the market growth during the forecast period. Now, moving forward, the robust demand for the Global DNA Sequencing Market in the DNA Sequencing department is further estimated to create new necessities and augment the market of growth over the forecast period of 2020-2030.
Market Insights
DNA sequencing is one of the most promising technology in the field of life science. Government as well as private labs use this technology to find the vaccines for lot of new as well as existing disease. Its growth is also attributed towards determining proofs in crime affected areas too.
Global DNA Sequencing Segment Is Estimated to Witness Remarkable Growth
Source: SAI Research
The DNA Sequencing market is segmented as product type, platform, application, and end-user. By Product Type, the global DNA Sequencing market has been bifurcated as Instruments, Consumables (Kits, Reagents), Acrylic, Epoxy, Polyurethane, and Others. By Platform, the global DNA Sequencing market is divided into Sanger, Next Generation Sequencing, qPCR, and Others. By Application, the global DNA Sequencing market has segmented as Diagnostics, Personalized Medicine, and Others (Biomarkers, Forensics, Reproductive Health, etc.). By End-User, the global DNA Sequencing market has been bifurcated as Hospitals and Healthcare Organizations, Academics and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others.
By Region, North America is Holding the Major Market Share
The DNA Sequencing Market has been geographically segmented into North America, Asia Pacific, Latin America, Middle East, and Africa region. In addition to this, North America has a significant share among those regions. The increasing prevalence of cancer among the geriatric population, large buying power, developed innovation ecology, and presence of major key players are the prime factor for the growth of the DNA sequencing market over the region. However, favorable rules and regulations and growing investment in the DNA research centers are factors for market growth. Apart from that, the Asia Pacific and the Rest of the regions are expected to increase the growth rate in the upcoming forecast period of 2020 to 2030.
Major Players in the Global DNA Sequencing Market
The report covers a detailed outlook about the company, and it includes the company or industry profiles and market share of key players operating in the global market. Key players in the report include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation (Beckman Coulter Inc.), Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., ZS Genetics, Beckman Coulter (Fullerton, CA), Abbott Laboratories, GE Healthcare Life Sciences, and Johnson & Johnson among others.
The Global DNA Sequencing Market Has Been Segmented into:
Global DNA Sequencing Market: By Product Type
Global DNA Sequencing Market: By Platform
Global DNA Sequencing Market: By Application
Global DNA Sequencing Market: By End-User
Global DNA Sequencing Market: By Region
Customization options available to meet your custom research requirements :